SOAT1 and psoriasis: In another internal project, tofacitinib was tested as JAK/STAT pathway inhibitor for the treatment of psoriasis, after incorporation into a cream and compared to Dermoval (GSK), a cream containing clobetasol propionate, commercialized against psoriasis lesions.